Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Boeing confirms China stopped taking deliveries amid trade war

(Sharecast News) - US aircraft maker Boeing posted better-than-expected results in the first three months of the year on the back of higher deliveries, and said it could hand some planes rejected by Chinese carriers due to tariffs to other customers.

The company narrowed losses to $31m in the three months to the end of March, compared with a $355m loss in 2024. Revenues increased 18% to $19.5bn, just above expectations of $19.45bn as aircraft deliveries rose to 130 from 83 the year before.

Free cashflow improved to negative $2.3bn, compared with negative $3.9bn. Production slumped last year on the back of a strike across its workforce and safety issues related to its 737 Max jet.

However, it is now dealing the fallout from tariffs imposed by US President Donald Trump. Chief executive Kelly Ortberg confirmed China had stopped taking deliveries of its planes amid the trade war.

"They have in fact stopped taking delivery of aircraft due to the tariff environment," Ortberg told CNBC, adding that a few 737 Max planes that were in China set to be delivered to carriers there had been flown back to the US.

Some jets that were intended for Chinese customers, as well as aircraft the company was planning to build for China later this year, could go to other customers, Ortberg said.

"There's plenty of customers out there looking for the Max aircraft. We're not going to wait too long. I'm not going to let this derail the recovery of our company."

Trump raised tariffs on Chinese imports to 145% earlier this month, to which Beijing hit back with 125% tariffs on US-made goods, including aircraft. That made the 737 MAX, worth $55m each, far less affordable for Chinese airlines.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.